HPV Newsletters

Insight HPV for PCPs - Summer 2005

Issue Date: January 3, 2006    Expires: January 3, 2009

This issue of Insight HPV reviews several case-based studies that illustrate the application of these new screening recommendations, as well as the diagnosis and treatment of condyloma acuminata (genital warts), the most easily recognized sign of genital HPV infection. This issue also features answers to several provocative questions posed at a series of HPV webcasts that aired this spring.

This program is designated for a maximum of 0.5 credits in category 1 of the Physician's Recognition Award of the American Medical Association.

Release Date: January 3, 2006
Expiration Date: January 3, 2009

Learning Objectives

After reading this publication, the participant should be able to:

• Identify knowledge gaps about STDs and HPV within the patient population;
• Understand the importance of patient education in the prevention of HPV infection and transmission;
• Provide patients with several educational resources and a clear understanding of how HPV is contracted, transmitted, and prevented;
• Identify HPV management and prevention strategies, including the use of new vaccines.

Faculty

Jeffrey Lin, MD, FACOG

Associate Professor
Director, Divisions of Gynecologic Oncology and General Obstetrics and Gynecology Chief, Gynecologic Surgery
The George Washington University Medical Center
Washington, DC

J.Thomas Cox, MD

Director of the Gynecology and Colposcopy Clinic University of California, Santa Barbara
Past Executive Medical Director National HPV and Cervical Cancer Prevention Resource Center, American Social Health Association Raleigh-Durham, NC
Diclosures: Dr. Cox participates in speakers' bureaus for Digene and 3M Pharmaceuticals. He also serves as a consultant to Digene and 3M Pharmaceuticals. Dr. Cox serves on the data and safety monitoring board for Merck and Co.'s worldwide quadrivalent HPV vaccine.

Martin Mahoney, MD, PhD

Associate Professor of Family Medicine, Assistant Research Professor of Epidemiology
Chair, Department of Health Behavior Division of Cancer Prevention and Population Sciences Roswell Park Cancer Institute
University at Buffalo
Buffalo, NY
Disclosures: Dr. Mahoney has served on an advisory board for Merck & Co.

Kevin A. Ault, MD

Associate Professor
Department of Obstetrics and Gynecology
Emory University
Woodruff Health Sciences Center
Atlanta, GA
Disclosures: Dr. Ault has received grant/research support from Merck & Co., GlaxoSmithKline, 3M, and Procter & Gamble Pharmaceuticals. Dr. Ault has served as a consultant to Merck & Co., 3M, and GlaxoSmithKline. Dr. Ault also has served on an advisory board for Merck & Co.

About this CME Activity

The George Washington University Medical Center designates this educational activity for a maximum of .5 credits in category 1 of the AMA Physicians' Recognition Award. Each physician should claim only those hours of credit that he or she actually spent in the educational activity.